Israel Chemicals Ltd. (ICL) Is At $4.94 Formed Wedge; Last Week CVR Partners, LP (UAN) Analysts

Israel Chemicals Ltd. (NYSE:ICL) Logo

Among 2 analysts covering CVR Partners (NYSE:UAN), 2 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. CVR Partners had 9 analyst reports since August 5, 2015 according to SRatingsIntel. As per Wednesday, August 23, the company rating was maintained by Cowen & Co. Cowen & Co maintained it with “Hold” rating and $3.0 target in Tuesday, September 26 report. Cowen & Co maintained it with “Hold” rating and $500 target in Wednesday, August 9 report. The firm has “Buy” rating by Cowen & Co given on Monday, March 5. Zacks upgraded CVR Partners, LP (NYSE:UAN) rating on Wednesday, August 5. Zacks has “Hold” rating and $14 target. The company was upgraded on Monday, March 20 by Goldman Sachs. The stock has “Hold” rating by Cowen & Co on Friday, July 7. See CVR Partners, LP (NYSE:UAN) latest ratings:

05/03/2018 Broker: Cowen & Co Rating: Buy Upgrade

Israel Chemicals Ltd. (ICL) formed wedge up with $5.14 target or 4.00% above today’s $4.94 share price. Israel Chemicals Ltd. (ICL) has $6.32B valuation. The stock increased 2.70% or $0.13 during the last trading session, reaching $4.94. About 242,947 shares traded or 27.51% up from the average. Israel Chemicals Ltd. (NYSE:ICL) has risen 7.89% since June 14, 2017 and is uptrending. It has underperformed by 4.68% the S&P500. Some Historical ICL News: ; 07/03/2018 – ICL Announces the Filing of its Annual Report on Form 20-F for Fiscal Year 2017; 28/03/2018 – SK Capital Closes Acquisition of the Fire Safety and Oil Additives Businesses from Israel Chemicals Ltd. and Changes Name to; 21/05/2018 – Israel Chemicals (“ICL”) Announces Pricing of Cash Tender Offer for Existing Notes; 08/03/2018 – ISRAEL CHEMICALS EXAMINING STRATEGIC PARTNERSHIPS IN INNOVATION; 17/05/2018 – ICL: PETITION FILED AGAINST PERMITS FOR ROTEM’S PONDS 4 AND 5; 28/03/2018 – ICL SEES RECORDING CAPITAL GAIN ABOUT $840M IN 1Q; 10/05/2018 – S&PGR Affirms Israel Chemicals At ‘BBB-‘; Outlook Stable; 21/05/2018 – ICL ANNOUNCES PRICING OF CASH TENDER OFFER FOR EXISTING NOTES; 23/05/2018 – Israel Chemicals (“ICL”) Announces Final Results of Cash Tender Offer for Existing Notes; 31/05/2018 – ISRAEL CHEMICALS- COMPLETED PRIVATE OFFERING OF $600 MLN AGGREGATE AMOUNT OF SENIOR UNSECURED NOTES DUE MAY 31, 2038 TO INSTITUTIONAL INVESTORS

Among 4 analysts covering Israel Chemical (NYSE:ICL), 0 have Buy rating, 1 Sell and 3 Hold. Therefore 0 are positive. Israel Chemical had 8 analyst reports since September 22, 2015 according to SRatingsIntel. The rating was maintained by Barclays Capital on Tuesday, January 12 with “Equal Weight”. The rating was maintained by BMO Capital Markets with “Hold” on Friday, September 1. Goldman Sachs downgraded the stock to “Sell” rating in Tuesday, September 22 report. The stock of Israel Chemicals Ltd. (NYSE:ICL) earned “Hold” rating by BMO Capital Markets on Thursday, October 5. The rating was initiated by Jefferies on Thursday, May 25 with “Hold”. BMO Capital Markets maintained the stock with “Hold” rating in Wednesday, November 8 report. On Thursday, July 6 the stock rating was maintained by BMO Capital Markets with “Hold”.

Analysts await Israel Chemicals Ltd. (NYSE:ICL) to report earnings on August, 2. They expect $0.09 earnings per share, up 80.00% or $0.04 from last year’s $0.05 per share. ICL’s profit will be $115.21M for 13.72 P/E if the $0.09 EPS becomes a reality. After $0.08 actual earnings per share reported by Israel Chemicals Ltd. for the previous quarter, Wall Street now forecasts 12.50% EPS growth.

Investors sentiment increased to 1.27 in Q1 2018. Its up 0.03, from 1.24 in 2017Q4. It is positive, as 5 investors sold CVR Partners, LP shares while 10 reduced holdings. 8 funds opened positions while 11 raised stakes. 36.61 million shares or 5.21% more from 34.80 million shares in 2017Q4 were reported. Morgan Stanley owns 2.87M shares or 0% of their US portfolio. Fmr Ltd Liability Corp has invested 0% in CVR Partners, LP (NYSE:UAN). San Francisco Sentry Inv Grp Inc (Ca) holds 473 shares. Greenwich Inv Inc accumulated 0.09% or 23,099 shares. Pekin Singer Strauss Asset Management Il invested in 0.01% or 10,000 shares. Susquehanna Group Limited Liability Partnership reported 0% in CVR Partners, LP (NYSE:UAN). Royal Bankshares Of Canada invested 0% of its portfolio in CVR Partners, LP (NYSE:UAN). 144,216 are held by Lpl Fincl Limited Liability Company. Jpmorgan Chase And Co accumulated 2.04M shares or 0% of the stock. Raging Management Limited Liability Corporation accumulated 9.57 million shares. Deutsche Commercial Bank Ag accumulated 3,702 shares. Glendon Capital Mngmt Ltd Partnership invested in 0.44% or 546,279 shares. California Employees Retirement System has 0% invested in CVR Partners, LP (NYSE:UAN) for 170,100 shares. Marco Mgmt Limited Liability Corp reported 23,528 shares. The New York-based Indexiq Advisors Llc has invested 0% in CVR Partners, LP (NYSE:UAN).

CVR Partners, LP (NYSE:UAN) Institutional Positions Chart